Answers are grounded in this paper and cite their sources.
Observational analysis shows enhanced antibacterial activity against multidrug-resistant bacteria with nanocomposites, indicating a potential solution for antibiotic resistance.
Hospital-acquired infections are a growing concern for healthcare providers worldwide. Recently, attention has been devoted to new and emerging nanoparticle-based materials that can help antibiotics destroy multidrug-resistant bacteria. In this work, we conjugated two commercial antibiotics, ampicillin or chloramphenicol, with carbon dots (CDs), forming novel nanoantibiotic-CDs nanocomposites in order to enhance their activity against multidrug-resistant bacteria. These CDs-antibiotics composites were about 4-7 nm in size and were prepared by sonication of poly-(ethylene glycol) (PEG)-400 and the antibiotic drug without using a catalyst. The antibacterial activity of the composites was tested and showed a 4-fold effect in the case of chloramphenicol and at least a 2-fold effect in the case of ampicillin, as compared to the unbound drugs. This method may provide a simple strategy to bring back the use of antibiotics that are no longer clinically relevant due to the increase in antibiotic resistance.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: